TheEdgeResearch
Home / Stocks / OPRX

OptimizeRx Corp. (OPRX)

NASDAQ Healthcare Medical - Healthcare Information Services
$6.70 ▼ -4.42%
Market Cap
$126.7M
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Beta
1.15
52-Wk Range
4.54-15.59
CEO
Stephen L. Silvestro
Country
US
Currency
USD

OptimizeRx Corp. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Waltham, MA, US. The stock last traded at $6.70, down 4.42% on the session, giving a market capitalisation of $126.7M. On trailing twelve-month figures it carries a trailing P/E of 25.42, a net margin of 5.3%. Its beta of 1.15 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
25.42
Price / Sales
1.34
Price / Book
0.94
EV / EBITDA
7.22
Gross margin
74.2%
Operating margin
12.6%
Net margin
5.3%
Return on equity
—
Debt / equity
0.10
Current ratio
5.06
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
133
IPO date
2007-11-28
Headquarters
Waltham, MA, US
About OptimizeRx Corp.

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Comparable companies

OptimizeRx Corp. is most often compared with the following Healthcare names:

DHDRUGNAKANRCRXSTSLPSMLRSOPHSPOKTBRG
More research on OPRX
OPRX technical analysis OPRX TheEdge Score Compare against peers
Open full interactive analysis & DCF →